HOME >> BIOLOGY >> NEWS
Experimental Biology 2004 meets in Washington, D.C. April 17-21

What: Experimental Biology 2004 will bring together more than 12,000 independent scientists, representing 32 different biological and biomedical societies from the United States and other nations. Now in its 14th year, Experimental Biology has become one of the world's largest and most significant interdisciplinary scientific meetings. Under the theme "Translating the Genome," this year's meeting offers thousands of individual presentations of new research, symposia on timely topics, lectures by internationally prominent distinguished scientists, and sessions on new technology and other topics of interest to practicing scientists and those who cover science. Reporters covering Experimental Biology 2004 have an opportunity to hear first-hand the research findings upon which scientific advances are made and to see interdisciplinary science and debate in action.

When: Saturday, April 17 Wednesday, April 21

Where: Washington, D.C. Convention Center

Who: Sponsoring scientific societies are the American Association of Anatomists, The American Association of Immunologists, The American Physiological Society, American Society for Investigative Pathology, American Society for Nutritional Sciences, and American Society for Pharmacology and Experimental Therapeutics. Another 26 participating societies are also represented.

Why this meeting is important to science: Whatever their field of study, scientists participating in Experimental Biology 2004 share an interest in the processes underlying human development, function, and aging, and the way diseases develop and can be treated or prevented. The interdisciplinary nature of the meeting provides scientists the opportunity to explore how their work whether in anatomy, pathology, physiology, nutrition, pharmacology, immunology, or other fields relates to research in other disciplines.

Media Contact: For information and to register for the mee
'"/>

Contact: Sarah Goodwin
eb4press@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
14-Dec-2003


Page: 1 2 3

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental hantavirus vaccine elicits strong antibody response in primates
6. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
Breaking Biology Technology:
Cached News: